Related Experiment Video

Updated: Sep 30, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Gestational diabetes and its impact on the neonate

C W Jones1

  • 1Neonatal Intensive Care Unit, Carolinas Medical Center, Charlotte, North Carolina 28232, USA. cjones30@carolina.rr.com

Neonatal Network : NN
|July 30, 2002
PubMed

Insights

Gestational diabetes mellitus (GDM) impacts maternal and fetal health, leading to various neonatal complications. This review details GDM pathophysiology, infant outcomes, and current treatment strategies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Endocrinology

Background:

  • Gestational diabetes mellitus (GDM) is a prevalent condition with historical roots.
  • Maternal hyperglycemia in GDM significantly affects fetal development and neonatal well-being.

Purpose of the Study:

  • To comprehensively review the pathophysiology of GDM in mothers and fetuses.
  • To elucidate the impact of maternal GDM on neonatal health and outcomes.
  • To discuss current therapeutic strategies and research advancements.

Main Methods:

  • Literature review of maternal and fetal pathophysiology.
  • Analysis of neonatal complications associated with maternal hyperglycemia.
  • Synthesis of information on therapeutic approaches and infant diagnosis.

Main Results:

  • Maternal hyperglycemia can lead to fetal macrosomia and various neonatal issues including respiratory distress, cardiomyopathy, hypoglycemia, hypocalcemia, hypomagnesemia, polycythemia, and hyperviscosity.
  • Detailed discussion of these specific neonatal manifestations.
  • Overview of maternal treatment options and infant diagnostic criteria.

Conclusions:

  • GDM necessitates careful maternal management to mitigate significant risks to the neonate.
  • Understanding the pathophysiology is crucial for effective diagnosis and treatment of both mother and infant.
  • Ongoing research aims to improve outcomes for GDM-affected pregnancies.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...